Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Two-Period Crossover Study to Compare the Systemic Exposure to Trans-Capsaicin and Cis-Capsaicin From an Intra-Articular Injection of CNTX-4975-05 (Trans-capsaicin for Injection) and Topical 8% Capsaicin Patch (Qutenza) in Subjects With Painful Knee Osteoarthritis

Trial Profile

A Two-Period Crossover Study to Compare the Systemic Exposure to Trans-Capsaicin and Cis-Capsaicin From an Intra-Articular Injection of CNTX-4975-05 (Trans-capsaicin for Injection) and Topical 8% Capsaicin Patch (Qutenza) in Subjects With Painful Knee Osteoarthritis

Completed
Phase of Trial: Phase I

Latest Information Update: 23 Nov 2018

At a glance

  • Drugs Capsaicin (Primary) ; Capsaicin
  • Indications Pain
  • Focus Pharmacokinetics
  • Sponsors Centrexion Therapeutics
  • Most Recent Events

    • 13 Nov 2018 Status changed from recruiting to completed.
    • 11 Sep 2018 Planned End Date changed from 1 Sep 2018 to 1 Oct 2018.
    • 06 Jul 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top